Gefitinib with pemetrexed as first-line therapy in patients with advanced nonsquamous non-small cell lung cancer with activating epidermal growth factor receptor mutations
Ann Transl Med
.
2017 Jan;5(1):11.
doi: 10.21037/atm.2016.12.64.
Authors
Shinkyo Yoon
1
,
Dae Ho Lee
1
,
Sang-We Kim
1
Affiliation
1
Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
PMID:
28164096
PMCID:
PMC5253295
DOI:
10.21037/atm.2016.12.64
No abstract available
Publication types
Editorial
Comment